Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
lung cancer treatment
Jun 8, 2024, 11:29 |
Insight
Key Insights You Don't Want to Miss - The Babak Lab
The Babak Lab shared on LinkedIn: "Weekly Digest: Key Insights You Don't Want to Miss!…
May 16, 2024, 01:05 |
Blog
Aakash Desai: We're Hiring: Clinical Research Coordinator II at UAB - Hematology & Oncology
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: "We're…
Apr 12, 2024, 03:19 |
Dialogues
OncoInfluencers: Dialogue with Pasi Jänne, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers,” hosted by Dr. Gevorg Tamamyan. In…
Feb 27, 2024, 15:14 |
Blog
Theodore DeWeese: Johns Hopkins Bayview Medical Center is older than the Constitution
Theodore DeWeese, Dean of the Medical Faculty and Chief Executive Officer of Johns Hopkins Medicine…
Oct 5, 2023, 17:14 |
Blog
Fabio Moraes: As co-chair of the WCLC24, I'm committed to delivering game-changing content and fostering a vibrant community.
Fabio Moraes, Radiation Oncologist and Innovation Professor at Queen's University Canada, recently shared on Twitter:…
Jun 19, 2023, 18:11 |
Drugs
Antibody-drug conjugates (ADCs) have emerged as one of the fastest-growing oncology therapeutics - Antonio Passaro
I am delighted to share the our recent publication in JCO titled "Antibody-Drug Conjugates in…
Oct 6, 2024, 16:44 |
Insight
Amrubicin + irinotecan vs cisplatin + irinotecan for SCLC
Stephen V Liu shared a post on X: "Randomized phase II: 1L amrubicin + irinotecan vs…
Oct 6, 2024, 14:01 |
Insight
MD Anderson Research Highlights
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Oct 6, 2024, 12:22 |
Insight
Stephen V Liu: Randomized phase II trial results on amrubicin vs cisplatin for SCLC
Stephen V Liu posted the following on X: “Randomized phase II: 1L amrubicin + irinotecan…
Oct 6, 2024, 12:15 |
Blog
Zainab Sani D: FRAGILE HOPE - A Caregivers Side Of the Story
Zainab Sani D., Executive Director, Paediatric Oncology Survivorship Initiative (POSI), shared a post on LinkedIn:…
39
40
41
42
43
All:
851
Posts:
401 - 410
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube